Literature DB >> 35747151

Associated risk factor analysis and the prognostic impact of positive resection margins after endoscopic resection in early esophageal squamous cell carcinoma.

Yong Feng1, Wei Wei2, Shuo Guo3, Bao-Qing Li1.   

Abstract

Endoscopic resection for early esophageal cancer has a risk of residual margins. The risk these residual margins pose have not been fully evaluated. The present study aimed to investigate the associated risk factors and prognosis of residual margins following the endoscopic resection of early esophageal squamous cell carcinoma. In total, 369 patients (381 lesions) with early esophageal squamous cell carcinoma treated in the Fourth Hospital of Hebei Medical University (Shijiazhuang, China) with endoscopic resection were retrospectively analyzed. Sex, age, location, tumor diameter, depth of tumor invasion, endoscopic treatment, endoscopic ultrasonography (EUS) before resection, work experience of endoscopists and the degree of tumor differentiation were all evaluated as potential risk factors. In addition, the prognosis of patients with positive margins were analyzed. A total of 73 patients (73/381, 19.2%) had positive margins after endoscopic resection. Amongst the 65 patients who were successfully followed up, five patients succumbed to cardiovascular and cerebrovascular diseases, one patient received radiotherapy, two patients received radiotherapy and chemotherapy whilst one patient received chemotherapy. By contrast, 12 patients received surgery and 20 patients received additional endoscopic mucosal resection or endoscopic submucosal dissection. The other 29 patients were followed up regularly and no recurrence could be found. Univariate analysis revealed that tumor diameter, endoscopic treatment, depth of invasion, EUS before resection, degree of tumor differentiation and direction of invasion were all associated with the positive margin. Multivariate logistic regression analysis then found that EUS before resection, degree of tumor differentiation and depth of tumor invasion are independent risk factors for positive margins after endoscopic resection. These results suggest that poorly differentiated lesions and deeper invasion depth can increase the risk of positive margin after endoscopic resection. As a result, EUS evaluation before resection may reduce the risk of invasion depth. In addition, for poorly differentiated lesions, more aggressive treatment regimens may be recommended for preventing recurrence. Copyright: © Feng et al.

Entities:  

Keywords:  early esophageal carcinoma; endoscopic treatment; positive resection margins; risk factors

Year:  2022        PMID: 35747151      PMCID: PMC9204577          DOI: 10.3892/etm.2022.11384

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.751


Introduction

Esophageal cancer is a common type digestive system malignancy and currently ranks sixth in terms of the rate of cancer-associated mortality worldwide (1). Despite progress in the development of novel treatment strategies, the 5-year survival rate of esophageal cancer remains <20% (2). Esophageal cancer in the early stages is confined to the mucosa or superficial submucosa and accounts ~20% of all types of esophageal cancers (3). Surgical resection has long been the standard treatment method for early esophageal cancer (4). However, the high incidence of complications (such as gastroesophageal reflux and respiratory failure) as a result of this technique renders it unattractive, due to its severe negative effects on the quality of life of patients (4). Nevertheless, the development of gastroscopy has greatly improved the quality of life of patients with early esophageal cancer. As advancements in endoscopic technology are made continuously, endoscopic resection is becoming the standard, minimally invasive treatment procedure for early esophageal cancer (5-7). It has been found to shorten the length of hospital stay and reduce the incidence of complications without affecting the quality of life, compared with those after esophagectomy (5-7). However, similar to traditional esophagectomy, endoscopic resection also has the risk of a positive margin (positive margin refers to the presence of atypical cells at the lateral or deep resection margins). Positive margin after the endoscopic resection of early esophageal carcinoma has direct implications on the choice of treatment and disease prognosis (8). To date, previous studies of patients with early esophageal cancer (9-11) after undergoing endoscopic submucosal dissection (ESD) have produced sporadic results based on a small number of cases. Amongst the available reports on positive margins, there are no reports of multicenter, large-sample trials with long-term follow-up periods. Therefore, to explore methods of improving the prognosis of patients after the endoscopic resection of esophageal cancer, the present study investigated the potential risk factors for positive margins by comprehensively analyzing clinical and pathological data.

Materials and methods

Patients

The present study retrospectively analyzed the clinical, endoscopic and pathological data of patients with esophageal mucosal lesions treated with endoscopic resection in the Fourth Hospital of Hebei Medical University (Shijiazhuang, China) from January 2011 to December 2020. The inclusion criteria of the lesions were as follows: i) Complete resection of lesions; ii) pathological diagnosis after endoscopic treatment was atypical cells (cells that looked different and function differently than normal) [low-grade intraepithelial neoplasia (LIN), high-grade intraepithelial neoplasia (HIN) or invasive cancer]; and iii) patients provided informed consent. The exclusion criterion was patients who were pathologically diagnosed with adenocarcinoma or inflammation after endoscopic treatment. Of note, intraepithelial neoplasia was defined as the neoplastic change before epithelial invasion, which can be divided further into ‘low-grade’ and ‘high-grade’ according to whether the structural and cytological abnormalities observed occupy the upper part of the epithelium (12). A total of 369 patients (381 lesions) received endoscopic resection due to early esophageal carcinoma. Of these, 236 were males and 133 were females with a mean age of 63.5±9.9 years. The main clinical symptoms were retropharyngeal asphyxia and retrosternal pain. No other symptoms or findings could be observed during physical examination. All patients and their relatives were aware of the risks and benefits of endoscopic resection, following which written informed consent was obtained from all participants. The present study was approved by the Ethics committee of the Fourth Hospital of Hebei Medical University (Shijiazhuang, China).

Endoscopic treatment and pathological examination

Under the guidance of endoscopy, two treatment methods were used to remove the tumor: Endoscopic mucosal resection (EMR) and ESD.

Endoscopy-guided surgery

The type of endoscopic treatment performed in the present study was by professionally trained endoscopists using a single-channel endoscope (Olympus H260; Olympus Corporation). Argon plasma coagulation (APC; APC probes for flexible endoscope; Erbe Elektromedizin GmbH) was used to mark ~5 mm outside the boundary of the lesion. After fully marking the border, an epinephrine-containing hypertonic saline solution was injected into the submucosa for submucosal lifting. A circumferential mucosal incision was then created around the marking spots. In cases where the EMR technique was used, asymmetrical polypectomy snare (MTW Endoskopie) resection was initiated. For ESD, the submucosal layer was dissected using the IT-knife2 (KD-611L; Olympus Corporation). After the lesions were resected, the wounds were closed with APC, hot biopsy forceps coagulation or using titanium clips according to the wound conditions (Fig. 1A and B). The lesion was completely removed en bloc (Fig. 1C). The pathologist then evaluated tumor involvement in the lateral or deep resection margin (Fig. 1D).
Figure 1

Endoscopic resection procedure for early esophageal squamous cell cancer. (A) Upper gastrointestinal endoscopy revealed a lesion located at the middle esophagus (the lesion is indicated by arrows). (B) Upper gastrointestinal endoscopy image of the esophagus after endoscopic resection. (C) En bloc image of the resected specimen, 6x4 cm (the lesion was indicated by arrows). (D) High-grade intraepithelial neoplasia in the deep resection margin as shown by H&E staining. The lesion was indicated by arrows. Magnification, x200.

Post-operative pathological examination

The resected specimens were processed and fixed immediately, before the lesion size was measured. After fixation with 10% formalin (20-25˚C for 12-24 h), the specimens were sent for pathological examination. The samples were cut into continuous sections at 2-mm intervals from top to bottom and embedded in paraffin. In total, three sections were prepared from each tissue and then stained with hematoxylin and eosin using the Ventana HE 600 automatic staining machine (Roche Diagnostics; 20-25˚C). An experienced pathologist (Dr Yao Liu, Department of Pathology, Fourth Hospital of Hebei Medical University) then used a light microscope (DM1000; Leica Microsystems GmbH; magnification, x200) to evaluate tumor involvement in the lateral or deep resection margin to avoid misjudgment. When examining the tissue sections for pathological evaluation, all sections were observed from the top of the tissue to identify the nature of the lesion, the degree of tumor differentiation, whether the vertical/transverse edge of the tumor was positive and whether there was vascular infiltration. A positive resection margin as defined as the presence of atypical cells (LIN, HIN or invasive cancer) at the lateral or deep resection margin.

Statistical analysis

Sex, age, lesion location, tumor diameter, depth of invasion, endoscopic treatment, endoscopic ultrasonography (EUS) before resection, working experience of the endoscopist and degree of tumor differentiation were all analyzed as potential risk factors. Continuous data are presented as the mean ± standard deviation. χ2 and nonparametric Mann-Whitney U tests were used for statistical analysis. Univariate and multivariate logistic regression models were used to examine the association between the variables and positive margins risk factors. P<0.05 was considered to indicate a statistically significant significance. The SPSS vl9.0 (IBM Corp.) was used for data processing.

Results

General data

The present study was a retrospective analysis of the data collected from 369 patients with early esophageal cancer who met the inclusion criteria. Among all study participants, 236 were male and 133 were female with a ratio of 1.8:1. The average age was 63.5±9.9 (range, 31-85) years.

Residues at the resection margin and follow-up data

In total, 73 patients had positive margin, such that the positive rate was 19.2%, where 64 (16.8%) were positive for lateral margins and nine (2.4%) were positive for vertical margins. In addition, it was found that the residual rates of EMR and ESD were 26.9 and 16.7%, respectively. Only 7.5% (23/308) poorly differentiated lesions were diagnosed in negative margins. By contrast, the proportion of positive margin specimens was 28.8% (21/73). There was no vascular invasion or submucosal lymphatic metastasis. After communicating with the patients and their families, 29 patients asked for regular follow-up, while others with positive margins received another ESD or EMR and were followed up 1 month after operation. During the follow-up period, endoscopy was performed 3, 6 and 12 months after endoscopic resection, before being performed every year thereafter. Chest CT was also performed 6 and 12 months after endoscopic resection followed by once a year thereafter as a precaution for distant metastasis. Follow up was halted 5 years after endoscopic resection. If tumor cells were found at the edge of the deep resection, additional esophagectomy or esophageal radiotherapy and chemotherapy would be performed. These treatment options were selected according to the situation of each patient and the wishes of patients and their families. In the present study, 65 cases of residual tumors were successfully followed up for 2-60 months, with an average follow-up time of 28.1±10.1 months. The follow-up rate was 89%. However, eight patients were lost to follow-up. During the follow-up, five patients succumbed to cardiovascular and cerebrovascular diseases, whilst the other 60 patients remained alive during the follow-up period.

Comparison of groups with or without residual margins

A number of associated factors can affect the residual margin, including sex, age, lesion location, tumor diameter, depth of invasion, endoscopic treatment, EUS before resection, working experience of the endoscopist and degree of tumor differentiation (12). Univariate and multivariate analyses were performed to determine if any of these factors can affect the residual margin after endoscopic resection. As shown in Table I, there was no significant difference in sex, age, lesion location or working experience of endoscopists in the univariate analysis of incision margins. By contrast, tumor diameter, endoscopic treatment, depth of invasion, EUS before resection and the degree of tumor differentiation were all risk factors for residual margins. To exclude any confounding factors, multivariate logistic regression analysis (Table II) was performed. Only the depth of tumor invasion, degree of differentiation and EUS before resection were regarded to be risk factors for residual margins.
Table I

Comparison of the groups with and without post-endoscopic resection residues at resection margins.

ParameterResidues at resection margin (n=73)No Residues at resection margin (n=308)P-value
Age (years)64.8±8.960.9±11.40.891
Sex  0.435
     Female23112 
     Male50196 
Location  0.136
     Upper323 
     Middle42201 
     Lower2884 
Tumor diameter  <0.001
     ≤1 cm229 
     1.1-3 cm28190 
     >3 cm4389 
Endoscopic treatment methods  0.03
     Endoscopic mucosal resection2568 
     Endoscopic submucosal dissection48240 
Endoscopic ultrasonography evaluation before resection  <0.001
     Yes42257 
     No3151 
Working experience  0.673
     ≥5 years45198 
     <5 years28110 
Depth of invasion  <0.001
     Intramucosal cancer (M1)30208 
     Lamina propria (M2)1133 
     Muscularis mucosa (M3)945 
Shallow and deep submucosal layer (SM1-2)2322 
Differentiation  <0.001
     Well23233 
     Moderate2952 
     Poor2123 
Table II

Results of multivariate logistic regression analysis.

ParameterP-valueOdds ratio95% Confidence interval
Age0.8201.0510.686-1.610
Sex0.4370.7630.385-1.510
Maximum diameter of resected specimen0.391.3250.698-2.515
Location0.6631.1870.549-2.564
Endoscopic resection procedures0.5260.7740.350-1.710
Depth of tumor invasion<0.0012.1821.704-2.795
Work experience0.1550.6240.325-1.196
Degree of tumor differentiation0.0180.4510.166-1.224
Endoscopic ultrasonography before resection<0.00135.8267.400-173.454

Discussion

Applications of EMR and ESD are becoming increasingly common for the treatment of early esophageal cancer (7). Endoscopic resection is able to not only preserve the integrity of the esophagus, but also circumvent the considerable risk of morbidity and mortality associated with esophageal resection (13). Previous studies have reported that although the effect of endoscopic resection on early esophageal cancer is equivalent to that of surgical resection, a lower incidence of complications and superior quality of life was associated with endoscopic resection (5,7). Several cohort studies (14-17) have recommended the use of EMR or ESD for T1a esophageal tumors, including highly atypical hyperplasia, adenocarcinoma or squamous cell carcinoma, which are limited to the superficial mucosa and do not extend to the muscular mucosa. In addition, Manner et al (18) have evaluated the efficacy and safety of endoscopic resection in selected cases with mucosal myometrial infiltration and upper third submucosal involvement. These studies further verified the application of endoscopic resection in early esophageal cancer. After the endoscopic resection of early esophageal cancer, the positive rate of resection edge varies greatly according to the literature, ranging 1.7-22% (9-11). In the present study, observation of atypical cells (including LIN, HIN or invasive cancer) at the resection margin was used as the criteria, where the positive rate of the resection margin was 19.2%. If only invasive cancer was considered, the positive rate of the resection edge then decreases to 5.4%. Previous studies have found that ESD has a higher en bloc resection and complete resection rates compared with those following traditional EMR (19-21). This finding is consistent with results from the present study, which found that the residual rates of EMR and ESD were 26.9 and 16.7%, respectively. However, based on logistic regression analysis, endoscopic resection was not found to be an independent risk factor, which is consistent with the results of Sgourakis et al (22). This finding may be associated with the results of retrospective analysis and not to the results of randomized controlled trials. Over recent years, an increasing number of gastroenterologists in China consider ESD to be the optimal choice for the treatment of early esophageal cancer (23,24). They believe that with continuous advancements in ESD, the incidence of serious complications, such as perforation and bleeding, can be controlled to negligible levels (23-25). These studies further confirm that ESD is safe and effective in the treatment of early esophageal cancer. Isomoto et al (26) previously reported that tumor size had no significant association with curative resection. However, the tumor size was significantly associated with segmental resection, where the cure resection rate was significantly lower compared with that of whole resection (26,27). In the present study, univariate analysis revealed that the maximum diameter of the primary tumor was associated with residual margin, but not in the multivariate analysis, which may be due to the nonrandomized endoscopic treatment methods (EMR and ESD) in the present retrospective analysis. In addition, the present study found that preoperative EUS examination and depth of tumor invasion are independent risk factors for residual resection margin. Previous studies have shown that EUS is the optimal noninvasive tool for T1 esophageal cancer, with a sensitivity of 85% and a specificity of 87% (28,29). This finding was also illustrated in previous studies of gastrointestinal neuroendocrine tumors (30,31) and is consistent with results from the present study. Preoperative evaluation of the depth of tumor invasion can minimize the residual edge of deep resection (32). Lugol iodine staining, NBI amplification and EUS can all be used to evaluate lesion size and depth of tumor invasion (33,34). Through the above methods, it is possible to reduce the residual margin in the process of endoscopic resection. Furthermore, unnecessary resection should be avoided to prevent esophageal stenosis. The degree of tumor differentiation has also been previously established to be an independent risk factor (31,35-37). However, no similar reports exist regarding esophageal cancer. Poorly differentiated tumors are typically more likely to invade the vascular system and lymph nodes earlier or cause deep infiltration (38). In the present study, only 23 (7.5%) poorly differentiated lesions were diagnosed in 308 specimens with negative margins. By contrast, the proportion of positive margin specimens (21 poorly differentiated, representing 28.8% of 73 specimens) was significantly higher compared with that of negative margin specimens. In a previous study with gastric cancer, in the high-risk category, the benefit of surgery appears to be positive, since the cancer-specific survival rate in the salvage surgery group was higher compared that in the follow-up group (39). These data suggest that if biopsy indicates poorly differentiated tumors and if the patient's physical conditions allow, more aggressive treatment strategies should be recommended. Due to the limited follow-up time, no corresponding data were available and these patients require continuous close attention. It remains unclear whether surgery and other medical interventions should be actively performed for patients with residual margins after endoscopic resection. For the designation of subsequent treatment plans, the patient's age, complications and willingness should also be considered. In this group of data, amongst the nine patients with positive deep margins, six patients received surgical treatment, two patients received radiotherapy and chemotherapy, whereas one patient was closely observed. No recurrence was found during the follow-up. Among the 64 patients with positive lateral margins, one patient received radiotherapy, one patient received chemotherapy, six patients received surgical treatment, 20 patients received additional EMR or ESD, eight patients were lost to follow-up and the remaining 28 patients were closely observed. During the follow-up period, five patients succumbed to cardiovascular and cerebrovascular diseases whereas no recurrence was found in other patients. In the present study, a preliminary prognostic analysis of patients with positive margins after endoscopic resection of early esophageal cancer was performed. A more detailed prognostic analysis needs to be verified by a multicenter study with a longer term of follow-up. The present study has a number of limitations. The present study is only a retrospective single-center study, not a randomized controlled study. Only one pathologist participated in the analysis of the tissues. Therefore, there may be potential selection bias in the present study. Prospective clinical trials may be conducted in the future to further verify these results. In conclusion, the present study analyzed the risk factors associated with the residual margin and the prognosis of patients. According to the results of data analysis, it is highly recommended to apply EUS for evaluating the depth of tumor invasion, determining the depth of lesion invasion and the indication of endoscopic resection before operation, all of which can effectively prevent a residual margin. If biopsy indicates a poorly differentiated tumor, more aggressive treatment strategies may be required to prevent recurrence after endoscopic resection.
  38 in total

1.  Management of high-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus.

Authors:  Sachin Wani; Dayna Early; Steve Edmundowicz; Prateek Sharma
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-13       Impact factor: 11.382

2.  Associated risk factor analysis for positive resection margins after endoscopic submucosal dissection in early-stage gastric cancer.

Authors:  Jing Wen; En-Qiang Linghu; Yun-Sheng Yang; Qing-Sen Liu; Jing Yang; Zhong-Sheng Lu
Journal:  J BUON       Date:  2015 Mar-Apr       Impact factor: 2.533

3.  Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series.

Authors:  Alessandro Repici; Cesare Hassan; Alessandra Carlino; Nico Pagano; Angelo Zullo; Giacomo Rando; Giuseppe Strangio; Fabio Romeo; Rinaldo Nicita; Riccardo Rosati; Alberto Malesci
Journal:  Gastrointest Endosc       Date:  2010-04       Impact factor: 9.427

4.  Efficacy of Endoscopic Ultrasonography for Determining Clinical T Category for Esophageal Squamous Cell Carcinoma: Data From 1434 Surgical Cases.

Authors:  Jie Yang; Guang-Yu Luo; Run-Bin Liang; Tai-Shan Zeng; Hao Long; Jian-Hua Fu; Guo-Liang Xu; Mu-Zi Yang; Shuo Li; Lan-Jun Zhang; Peng Lin; Xin Wang; Xue Hou; Hao-Xian Yang
Journal:  Ann Surg Oncol       Date:  2018-04-17       Impact factor: 5.344

5.  Factors related to lateral margin positivity for cancer in gastric specimens of endoscopic submucosal dissection.

Authors:  Naomi Kakushima; Hiroyuki Ono; Masaki Tanaka; Kohei Takizawa; Yuichiro Yamaguchi; Hiroyuki Matsubayashi
Journal:  Dig Endosc       Date:  2011-01-06       Impact factor: 7.559

6.  Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms.

Authors:  Satoshi Ono; Mitsuhiro Fujishiro; Keiko Niimi; Osamu Goto; Shinya Kodashima; Nobutake Yamamichi; Masao Omata
Journal:  Gastrointest Endosc       Date:  2009-07-04       Impact factor: 9.427

7.  A scoring system for patients with a tumor-positive lateral resection margin after endoscopic resection of early gastric cancer.

Authors:  Jae Jin Hwang; Kwung Jun Park; Young Soo Park; Hye Seung Lee; Hyuk Yoon; Cheol Min Shin; Nayoung Kim; Dong Ho Lee
Journal:  Surg Endosc       Date:  2015-11-12       Impact factor: 4.584

8.  Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study.

Authors:  Waku Hatta; Takuji Gotoda; Tsuneo Oyama; Noboru Kawata; Akiko Takahashi; Yoshikazu Yoshifuku; Shu Hoteya; Masahiro Nakagawa; Masaaki Hirano; Mitsuru Esaki; Mitsuru Matsuda; Ken Ohnita; Kohei Yamanouchi; Motoyuki Yoshida; Osamu Dohi; Jun Takada; Keiko Tanaka; Shinya Yamada; Tsuyotoshi Tsuji; Hirotaka Ito; Yoshiaki Hayashi; Tomohiro Nakamura; Naoki Nakaya; Tooru Shimosegawa
Journal:  Gastric Cancer       Date:  2017-10-05       Impact factor: 7.370

9.  Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study.

Authors:  Ii-Kwun Chung; Jun Haeng Lee; Suck-Ho Lee; Sun-Joo Kim; Joo Young Cho; Won Young Cho; Young Hwangbo; Bo Ra Keum; Jong Jae Park; Hoon-Jai Chun; Hoi Jin Kim; Jae J Kim; Sam-Ryong Ji; Sang Young Seol
Journal:  Gastrointest Endosc       Date:  2009-02-27       Impact factor: 9.427

10.  Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society.

Authors:  Tsuneo Oyama; Haruhiro Inoue; Miwako Arima; Kumiko Momma; Tai Omori; Ryu Ishihara; Dai Hirasawa; Manabu Takeuchi; Akihisa Tomori; Kenichi Goda
Journal:  Esophagus       Date:  2016-04-06       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.